Opportunity
SAM #75N98026Q00848HAMAMATSU
NIH NEI Procurement of Hamamatsu Photomultiplier Sensors, Power Supplies, and Cables for Clinical Retinal Imaging
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
July 21, 2026
Respond By
July 30, 2026
Identifier
75N98026Q00848HAMAMATSU
NAICS
423490, 339115, 339112, 335999, 423460, 423410
This opportunity involves the National Eye Institute (NEI) under the National Institutes of Health (NIH) procuring specialized imaging hardware from Hamamatsu for clinical retinal imaging studies. - Government Buyer: - National Institutes of Health (NIH) - National Eye Institute (NEI) - Office of Acquisitions - OEM Highlight: - Hamamatsu is the specified Original Equipment Manufacturer for all requested components - Products Requested: - 3 Near Infrared Photomultiplier sensors (model H15620-25) - Key specs: control voltage +0.5V to +0.8V, 1.6mm sensing area, 950-1200 nm spectral response - 3 Power supplies (model C16137-C2) - Designed for H15620-25 sensors, with cooling and specific voltage/power requirements - 4 Signal cables (model MCAB-C16137-1550) - 5-foot cables for connecting Hamamatsu sensors and power supplies - Purpose and Notable Requirements: - Hardware will upgrade a custom-built adaptive optics scanning light ophthalmoscope (AOSLO) system - Supports advanced retinal imaging in clinical studies and trials - Enables detection of retinal biomarkers not visible with standard commercial devices - All components must be Hamamatsu OEM parts to ensure compatibility and performance - Delivery Requirement: - All items must be delivered within 180 days after contract award
Description
THE CUSTOM-BUILD AOSLO AT NEI CLINICAL SPACE OP10 HAS BEEN USED FOR PATIENTS IMAGING IN THE PAST A FEW YEARS TO STUDY RETINAL DISEASE. THE SOSLO SYSTEM REQUIRES REGULA UPDATE AND REFRESHING OF HARDWARE TO COMPLIES WITH NEI CLINICAL STUDIES AND CLINICAL TRAILS.
THESE NEAR INFRARED PHOTOMULTIPLIER SENSORS FOR THE EXISTING CUSTOM-BUILT AOSLO WILL ENABLE THE SYSTEM TO HAVE POTENTIALS TO FIND NEW RETINAL BIOMARKERS THAT CAN'T BE FOUND COMMERCIAL RETINAL IMAGING DEVICES, HENCE THE POTENTIALS TO EXPEDITE CLINICAL STUDIES AND CLINICAL TRIALS.